Exercise :: Exercise, exercise, rest, repeat – How a break can help your workout
Taking a break in the middle of your workout may metabolize more fat than exercising without stopping, according to a recent study in Japan.
Taking a break in the middle of your workout may metabolize more fat than exercising without stopping, according to a recent study in Japan.
Using selective cannabinoid 1 (CB1) receptor antagonists such as rimonabant at a dose of 20 mg per day can help people quit smoking, can help them to remain abstinent, and can help prevent the weight gain that so often accompanies attempts at stopping smoking.
New studies are needed to assess the trade-offs between potential benefits and potential harms when rosiglitazone is used by people with type 2 diabetes.
A review of published literature about benefits and harms of oral drugs for type 2 diabetes mellitus found that older agents, such as second-generation sulfonylureas and metformin, have similar or superior effects on glycemic control, lipids and other intermediate endpoints compared to newer, more expensive drugs, such as thiazolidinediones, alpha-glucosidase inhibitors and meglitinides.
Accepting food cravings and keeping them in check may be an important component of weight management, according to findings from the first six-month phase of a calorie-restriction study conducted at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University.
Every year, thousands of parents learn of their children’s food allergies following a reaction that can affect many body systems, including the respiratory system, the gastrointestinal tract, skin or cardiovascular system.
Orange juice, despite its high caloric load of sugars, appears to be a healthy food for diabetics due to its mother lode of flavonoids, a study by endocrinologists at the University at Buffalo has shown.
A commentary in the Journal of Clinical Oncology (JCO) urges researchers to explore an intriguing approach to reduce the dose, and therefore the cost, of oral targeted cancer therapies.
Researchers at Washington University School of Medicine in St. Louis have found that a protein absorbs lipids in the upper part of the intestine, and they believe its key role in this process may provide a novel approach for obesity treatment in the future.
It has long been known that type 1 diabetes is an autoimmune disease. The body attacks the islet cells in the pancreas that produce insulin.